Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

CAREFUSION ITALY 311 SRL

CAREFUSION ITALY 311 SRL is a federal contractor, registered under UEI SGNEY19R5MU7. It has been awarded $313,703 in federal contracts. Primary work spans Surgical and Medical Instrument Manufacturing, Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers, and Custom Computer Programming Services. Top awarding agencies include Department Of Defense.

Contact Information

Registration and classification details

Registration

UEI Code

SGNEY19R5MU7

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

9

All time

Active

0

Currently performing

Completed

9

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with CAREFUSION ITALY 311 SRL

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for CAREFUSION ITALY 311 SRL

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in CAREFUSION ITALY 311 SRL's top NAICS codes and agencies

NAICS: 339112
New
Federal
Operational Medicine Test and Evaluation Cell Salvage Supplemental - (AFMEDCOM)
Solicitation # FA800326SS004
The Department of Defense, through the Air Force Medical Service and the Operational Medicine Test and Evaluation cell, is conducting market research via solicitation FA800326SS004 to identify capabilities for a cell salvage, blood conditioning, and autonomous return device. The objective is to find a portable, shelf-stable solution to treat significant blood loss and hemorrhagic shock in austere, expeditionary environments, effectively bridging the time to surgery without relying on donor blood or cold-chain logistics. This effort is categorized under NAICS code 339112 for Surgical and Medical Instrument Manufacturing and is open to both large businesses and all categories of small business. Technical requirements for the device include a total system weight under 40 pounds, a volume under 8000 cubic inches, and a battery-powered runtime of 2 to 4 hours. Performance specifications require collection and return rates of 0 to 1500mL/min, the ability to heat 450cc of fluid from 2 to 37 degrees Celsius in under 20 minutes, and a priming sequence completed within 15 minutes by a single operator. The system must utilize FDA-approved or pending consumables, require no cold chain, and feature sterile packaging with a shelf life of at least one year. While not mandatory, there is a strong preference for man-portability and ruggedization meeting MIL-STD-810G standards for shock, vibration, and environmental extremes. This is a sources-sought Request for Information for market research purposes only and does not constitute a solicitation for proposals; therefore, no contract will be awarded directly from this announcement. Interested respondents must submit the required company and capability forms by November 16, 2026. All information shared within this RFI is confidential and intended solely for the government's market analysis to determine available industry capabilities.
FA8003 771 Enterprise Sourcing Squadron

POSTED

about 9 hours ago

DEADLINE

in about 1 month
View Details